Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor
PMID: 19687512
Gene: VWF
HGNCID: 12726
Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor
PMID: 19687512
Gene: VWF
HGNCID: 12726
Molecular findings:
Severe bleeding phenotype in homozygotes, alleviated bleeding phenotype in heterozygotes.
Difficult to classify based on the phenotype and plasma levels.
p.M771V variant shows elevated proVWF to mature VWF ratio, reduced levels of cleaved VWFpp.
p.M771V has potential to negatively influence VWFpp cleavage to contribute to decreased VWF processing in endothelial cells.
Other variants near p.M771 locus reported to disrupt the cleavage by furin. (Variants are at R763 and R760 respectively).
Other researchers have come across the p.M771 variant and reported it as well.
functional studies performed in cord blood derived ECFCs through adenine base editing and overexpressed in HEK293 cells.
Utilized Immunocytochemistry staining and confocal analysis
ELISA to test for secreted VWF in ECFCs
Multimer assay and densitometry graphs to view VWF multimer patterns
Western blotting to view proteolytic processing of VWF and VWFpp
Genomic sequencing to verify mutations.
Authors here used SpCas9-mediated base editing to mimic patient variant if primary ECFCs are not available or are difficult to culture to assist in improved characterization in a true endothelial background.
functional assays
Chemiluminescence assays (measuring binding capacity)
VWF-collagen binding assay (CBA)
Electrophoresis (Western blot)
Bidirectional direct sequencing of PCR products
Paternity test
PCR and restriction assays to detect SNVs
in vitro expression of recombinant WT and p.P1127S VWF variants in HEK293 cells
Platelet aggregation studies
DDAVP test
Binding assays
Proteolysis assays
in silico modeling
Tests performed: Haemostatic tests ristocetin-induced platelet aggregation plasma VWF antigen VWF risocetin cofactor VWF FVIII-binding capacity VWF multimers and FVIII activity DDAVP test Concentration timecourses
sequencing from genomic DNA performed and reported in 2011
cDNA analysis
Real-time-PCR analysis
long PCR
Ellman assay (quantifying sulfhydryls)
Dynamic light scattering measurements
circular dichroism
ADAMTS13 proteolysis assay
ADAMTS13-VWF binding assay
We were also aware that this method is subject to assay interference by thiol-containing compounds
this assay involves a thiol intermediate, so it will be interfered by thiol containing compounds, or compounds that react with thiol group. But common HTRF will not be affected.
Assay guidance
标签蛋白IP或基于标签的pull-down
a very good sumamry of the difference between Pull-down and IP assays. Pros and cons of both methods are described.
bead assay to measure compound binding
How does this assay work?
Here, we present the development and application of the BioMe plate, a redesigned microplate device in which pairs of wells are separated by porous membranes
Daley, J. (n.d.). Millions of Rapid COVID-19 Antigen Tests May Help Fill the Testing Gap. Scientific American. Retrieved September 30, 2020, from https://www.scientificamerican.com/article/millions-of-rapid-covid-19-antigen-tests-may-help-fill-the-testing-gap/
WHO. (n.d.) Coronavirus disease (COVID-19) technical guidance: Laboratory testing for 2019-nCoV in humans. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance
EPA Method 1603 is an approved drinking water assay that quantifies generic E. coli
This drinking water assay contains a membrane (0.45 µm) filtration step to remove bacteria from the water sample prior to enrichment on selective and differential media. The bacteria CFUs are quantified directly on the filter following a lengthy enrichment